EXL Stock Overview
Through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Elixinol Wellness Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.005 |
| 52 Week High | AU$0.015 |
| 52 Week Low | AU$0.003 |
| Beta | 2.28 |
| 11 Month Change | 25.00% |
| 3 Month Change | 25.00% |
| 1 Year Change | -66.66% |
| 33 Year Change | -94.32% |
| 5 Year Change | -99.53% |
| Change since IPO | -99.66% |
Recent News & Updates
Shareholder Returns
| EXL | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | -16.7% | -7.9% | 0.9% |
| 1Y | -66.7% | 54.5% | 17.7% |
Return vs Industry: EXL underperformed the Australian Personal Products industry which returned 54.5% over the past year.
Return vs Market: EXL underperformed the Australian Market which returned 17.7% over the past year.
Price Volatility
| EXL volatility | |
|---|---|
| EXL Average Weekly Movement | 35.4% |
| Personal Products Industry Average Movement | 5.5% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: EXL's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: EXL's weekly volatility (35%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | n/a | www.elixinolwellness.com |
Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021.
Elixinol Wellness Limited Fundamentals Summary
| EXL fundamental statistics | |
|---|---|
| Market cap | AU$7.80m |
| Earnings (TTM) | -AU$6.87m |
| Revenue (TTM) | AU$11.59m |
0.7x
P/S Ratio-1.1x
P/E RatioIs EXL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EXL income statement (TTM) | |
|---|---|
| Revenue | AU$11.59m |
| Cost of Revenue | AU$7.46m |
| Gross Profit | AU$4.13m |
| Other Expenses | AU$11.00m |
| Earnings | -AU$6.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0044 |
| Gross Margin | 35.65% |
| Net Profit Margin | -59.27% |
| Debt/Equity Ratio | 11.9% |
How did EXL perform over the long term?
See historical performance and comparison